title: Intraseptal infusion of oxotremorine impairs memory in a delayed-non-match-to-sample radial maze task.
abstract: The medial septal nucleus is part of the forebrain circuitry that supports memory. This nucleus is rich in cholinergic receptors and is a putative target for the development of cholinomimetic cognitive-enhancing drugs. Septal neurons, primarily cholinergic and GABAergic, innervate the entire hippocampal formation and regulate hippocampal formation physiology and emergent function. Direct intraseptal drug infusions can produce amnestic or promnestic effects depending upon the type of drug administered. However, intraseptal infusion of the cholinomimetic oxotremorine has been reported to produce both promnestic and amnestic effects when administered prior to task performance. The present study examined whether post-acquisition intraseptal infusion of oxotremorine would be promnestic or amnestic in a delayed-non-match-to-sample radial maze task. In this task rats must remember information about spatial locations visited during a daily sample session and maintain that information over extended retention intervals (hours) in order to perform accurately on the daily test session. Treatments may then be administered during the retention interval. Alterations in maze performance during the test session an hour or more after treatment evidences effects on memory. In the present study, intraseptal infusion of oxotremorine (1.0-10.0 microg) produced a linear dose-related impairment of memory performance. Importantly, we also observed disrupted performance on the day after treatment. This persistent deficit was related only to memory over the retention interval and did not affect indices of short-term memory (ability to avoid repetitive or proactive errors during both the pre- and post-delay sessions). The persistent deficit contrasts with the acute amnestic effects of other intraseptally administered drugs including the cholinomimetics carbachol and tacrine. Thus, intraseptal oxotremorine produced a preferential disruption of memory consolidation as well as a persistent alteration of medial septal circuits. These findings are discussed with regards to multi-stage models of hippocampal-dependent memory formation and the further development of therapeutic strategies in the treatment of mild cognitive impairment as well as age-related decline and Alzheimer's dementia.
authors.affiliation: Department of Psychology, University of Connecticut, Storrs, CT 06269, USA.
authors.forename: J G
authors.initials: JG
authors.lastname: Bunce
authors.forename: H R
authors.initials: HR
authors.lastname: Sabolek
authors.forename: J J
authors.initials: JJ
authors.lastname: Chrobak
mesh_terms: D000818:Animals; D001522:Behavior, Animal; D004193:Discrimination Learning; D004305:Dose-Response Relationship, Drug; D004333:Drug Administration Routes / Q000662:veterinary; D004334:Drug Administration Schedule; D008297:Male; D018782:Maze Learning / Q000187:drug effects*; D008569:Memory Disorders / Q000139:chemically induced*; D018721:Muscarinic Agonists / Q000009:adverse effects / Q000494:pharmacology; D010095:Oxotremorine / Q000009:adverse effects* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011930:Reaction Time / Q000187:drug effects; D012686:Septal Nuclei / Q000187:drug effects* / Q000502:physiology; D013037:Spatial Behavior / Q000187:drug effects; D013997:Time Factors
chemical_list: D018721:Muscarinic Agonists; D010095:Oxotremorine